BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17324658)

  • 21. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nutrition and cancer in pediatrics. A complex interaction].
    Fleta Zaragozano J; Moreno Aznar L; Bueno Lozano M
    An Esp Pediatr; 1989 May; 30(5):333-9. PubMed ID: 2502940
    [No Abstract]   [Full Text] [Related]  

  • 23. Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation.
    Lawson JD; Gaultney J; Saba N; Grist W; Davis L; Johnstone PA
    Am J Otolaryngol; 2009; 30(4):244-9. PubMed ID: 19563935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional support of patients undergoing radiation therapy for head and neck cancer.
    Colasanto JM; Prasad P; Nash MA; Decker RH; Wilson LD
    Oncology (Williston Park); 2005 Mar; 19(3):371-9; discussion 380-2, 387. PubMed ID: 15828552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer?
    Nyst HJ; Tan IB; Stewart FA; Balm AJ
    Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):3-11. PubMed ID: 19447366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer.
    Nouraei SA; Upile T; Al-Yaghchi C; Sandhu GS; Stewart S; Clarke PM; Sandison A
    Laryngoscope; 2008 May; 118(5):797-803. PubMed ID: 18520181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchus-associated B-cell lymphoma occurring after radiation and chemotherapy for head and neck Merkel cell carcinoma.
    Malani AK; Gupta C; Singh J; Ammar H
    Ann Hematol; 2006 Nov; 85(11):815-6. PubMed ID: 16941103
    [No Abstract]   [Full Text] [Related]  

  • 28. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
    Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
    Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer.
    Lawson JD; Otto K; Grist W; Johnstone PA
    Am J Otolaryngol; 2008; 29(1):13-9. PubMed ID: 18061826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.
    Marcu LG
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes.
    Rosenthal DI
    J Support Oncol; 2007 Oct; 5(9 Suppl 4):23-31. PubMed ID: 18046995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving strategies for combined-modality therapy for locally advanced head and neck cancer.
    Posner M
    Oncologist; 2007 Aug; 12(8):967-74. PubMed ID: 17766656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral management of patients following oncology treatment: literature review.
    Shaw MJ; Kumar ND; Duggal M; Fiske J; Lewis DA; Kinsella T; Nisbet T
    Br J Oral Maxillofac Surg; 2000 Oct; 38(5):519-24. PubMed ID: 11010786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral complications in radiation therapy.
    Harrison JS; Dale RA; Haveman CW; Redding SW
    Gen Dent; 2003; 51(6):552-60; quiz 561. PubMed ID: 15055655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement.
    Cady J
    Clin J Oncol Nurs; 2007 Dec; 11(6):875-80. PubMed ID: 18063546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
    Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
    J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysphagia in head and neck cancer.
    Manikantan K; Khode S; Sayed SI; Roe J; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
    Cancer Treat Rev; 2009 Dec; 35(8):724-32. PubMed ID: 19751966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.